phase 2_initiation
saveShanghai Henlius Biotech Inc — HLX-35 (Phase II Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Solid Tumor, Squamous Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Solid Tumor, Squamous Non-Small Cell Lung Cancer